Veterinary Clinical Reference
Look up any drug or condition.
Evergreen, evidence-based hubs on the drugs, conditions, and species you manage — continuously updated and cited at every claim.
Feline Ocular FIP and Anterior Uveitis: GS-441524 Treatment
Ocular FIP is a treatable pyogranulomatous panuveitis, not a death sentence. A practical hub on diagnosis, GS-441524/remdesivir dosing and ocular penetration, adjunct topical care, IOP monitoring, and prognosis for the practicing veterinarian.
Read →Canine Keratoconjunctivitis Sicca (KCS): Diagnosis and Treatment
A practical clinical hub on canine keratoconjunctivitis sicca: Schirmer tear test diagnosis and severity thresholds, topical calcineurin inhibitors (ciclosporin, tacrolimus) as first-line, tear replacement, oral pilocarpine for neurogenic KCS, parotid duct transposition for refractory cases, and where injectable PRP plus oral omega-3 fit as adjuncts.
Read →Canine Primary Glaucoma: Diagnosis and Management
A practical clinical reference on canine primary glaucoma: pathophysiology and goniodysgenesis, tonometry and gonioscopy, emergency IOP-lowering protocols, maintenance medical therapy, surgical options for sighted and blind eyes, and evidence-based fellow-eye prophylaxis.
Read →Feline Hypertrophic Cardiomyopathy: ACVIM Staging, Diagnosis, and Evidence-Based Management
A clinician-facing evidence hub on feline HCM: ACVIM 2020 staging, echocardiographic diagnosis, clopidogrel-based thromboprophylaxis with the FAT CAT trial and its 2024 absolute-benefit re-analysis, acute FATE management, and emerging myosin-inhibitor and rapamycin therapies.
Read →Canine Dilated Cardiomyopathy: Hereditary DCM, Diet-Associated DCM, Preclinical Screening, and Evidence-Based Management
DCM affects up to 58% of Dobermans; annual Holter screening recommended from age 3. FDA grain-free/DCM investigation closed Dec 2022 without confirmed caus
Read →Meloxicam for Canine Osteoarthritis Pain: Efficacy, Safety, and 2025 Head-to-Head vs. Bedinvetmab
Meloxicam (COX-2 NSAID) equals bedinvetmab for canine OA efficacy in 2025 RCT (n=101), with more GI adverse events. Standard dose: 0.2 mg/kg loading the...
Read →Doxycycline for Tick-Borne Disease in Dogs and Cats: Ehrlichia, Anaplasma, RMSF, and Lyme
Doxycycline 10 mg/kg/day for 28 days treats all major tick-borne infections in dogs and cats; short courses risk recrudescence. Esophageal stricture ris...
Read →Phenobarbital for Canine Idiopathic Epilepsy: Prescribing Patterns, Pharmacometrics, and TDM
Phenobarbital remains the most-prescribed first-line ASD for canine idiopathic epilepsy (34.9% in US primary care). A 2025 population PK model enables precision dosing, while TDM to a 20-35 ug/mL target stays essential and is itself assay-dependent.
Read →Amoxicillin-Clavulanate (Clavamox) in Dogs and Cats: Indications, Stewardship, and Skin and UTI Evidence
Amoxicillin-clavulanate covers beta-lactamase-producing Staphylococcus and E. coli in skin/UTI. ISCAID 2019 prefers amoxicillin alone for uncomplicated ...
Read →Canine Parvovirus Enteritis in Dogs: Pathophysiology, Diagnosis, and Evidence-Based Management
An evidence-based clinical reference on canine parvovirus (CPV-2) enteritis: diagnosis, supportive-care standard of care, CPMA (Trutect) efficacy and dosing, outpatient protocols, and post-prophylaxis vaccine timing.
Read →Prednisolone and Prednisone in Dogs and Cats: Pharmacology, Dosing, and Adverse Effect Management
Prednisolone is the preferred oral glucocorticoid in cats (~100% bioavailability vs ~21% for prednisone), while dogs treat the two as equivalent. A clinician-facing evidence summary of dosing, tapering, adverse effects, and steroid-sparing agents across dogs and cats.
Read →Methimazole and Carbimazole for Feline Hyperthyroidism: Pharmacology, Dosing, and Adverse Effect Management
Methimazole 1.25-2.5 mg PO BID is the standard medical therapy for feline hyperthyroidism, controlling but not curing disease. This hub consolidates dosing, adverse-effect management, carbimazole and transdermal options, and how medical management compares with radioiodine, iodine-restricted diet, and surgery — including the concurrent-CKD reversibility trial.
Read →